SciClone Pharmaceuticals, Inc. SCLN

Set alert

Price alert · SCLN

All alert types
11.15 0.00 0.00%

At close · Jun 28

11.15 Day range 11.20
8.55 52-week range 11.43
Open
11.15
Prev close
11.15
Mkt cap
0
Vol
2.22M
Avg vol
449.60K
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
11.15
High
11.20
Forward P/E
10.42
Beta
1.25
Short ratio
2.34
Inst. own
79.96%
Dividend
0.00
Ex-div date
Earnings
Nov 30, 2019
50-d avg
11.14
200-d avg
10.66
1y target
14.00

6M chart

Chart tools
Interval

Chart is warming up

The six-month price history for SCLN has not been loaded yet. Try again in a moment.

Analyst view

Consensus: hold

Hold
Price target (mean) 14.00
Ratings (-1m) 1 0 buy · 1 hold · 0 sell
  • Strong buy0
  • Buy0
  • Hold1
  • Sell0
  • Strong sell0

Recommendation trend

  • 1 month ago 1
  • 2 months ago 1
  • 3 months ago 1

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

SCLN analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter0.220.22 – 0.22-0.08+375.0%43.87M0.0%1
Next quarter0.210.21 – 0.210.12+75.0%44.29M+0.5%1
Current year0.940.94 – 0.940.58+62.1%173.72M+8.5%1
Next year1.071.07 – 1.070.94+13.8%185.57M+6.8%1

Upgrades and downgrades

The latest rating changes

SCLN analyst upgrades and downgrades
DateFirmActionFromTo
Nov 28, 2016Maxim GroupInitiated—Buy
Jun 28, 2015MLV & Co.Initiated—Buy
Nov 13, 2014BWS FinancialDowngrade—Hold
Jul 15, 2013Aegis CapitalUpgrade—Buy
Feb 24, 2013Aegis CapitalDowngrade—Hold
Sep 17, 2012BWS FinancialUpgrade—Buy